- Antiviral Effect of Entecavir Switching Therapy in Chronic Hepatitis B Patients with Clevudine-associated Myopathy
-
Tak WY
- KMID: 1775779
- Korean J Gastroenterol.
- 2013 Jan;61(1):1-2.
- doi: 10.4166/kjg.2013.61.1.1
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin
-
Kim YH, Han WS, Lee SJ, Oh SN, Choi DW, Byun KS, Yeon JE
- KMID: 760744
- Korean J Hepatol.
- 2007 Sep;13(3):419-422.
- doi: 10.3350/kjhep.2007.13.3.419
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN... -
- CITED
-
- Close
- SHARE
-
- Close
- Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin
-
Lee TH, Lee KO, Kim YS, Kim SM, Huh KC, Choi YW, Kang YW
- KMID: 1792063
- Korean J Intern Med.
- 2014 May;29(3):370-374.
- doi: 10.3904/kjim.2014.29.3.370
Various adverse events have been reported during combination therapy with pegylated (PEG)-interferon-alpha and ribavirin, although opportunistic infections, especially cryptococcal meningitis, are very rare. A 61-year-old woman complained of headaches and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Severe Peripheral Polyneuropathy Occurring after Entecavir Treatment in a Hepatitis B Patient
-
Song JH, Kim SY, Shin JK, Hong SD, Rim KS, Park HN, Lee JH, Lee YB, Oh SH, Hwang SG
- KMID: 2373428
- Korean J Gastroenterol.
- 2016 Apr;67(4):216-219.
- doi: 10.4166/kjg.2016.67.4.216
Entecavir (Baraclude®) is an oral antiviral drug used for the treatment of HBV. Entecavir is a reverse transcriptase inhibitor which prevents the HBV from multiplying. Most common adverse reactions caused... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B
-
Lee YS, Kim BK, Lee HJ, Dan J
- KMID: 2412353
- Clin Orthop Surg.
- 2016 Jun;8(2):232-236.
- doi: 10.4055/cios.2016.8.2.232
In Fanconi syndrome, hypophosphatemic osteomalacia is caused by proximal renal tubule dysfunction which leads to impaired reabsorption of amino acids, glucose, urate, and phosphate. We present a rare case of... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C
-
Shin MK, Kim TH, Ju K, Ha CY, Min HJ, Jung WT, Lee OJ
- KMID: 1374966
- Korean J Hepatol.
- 2009 Sep;15(3):370-374.
- doi: 10.3350/kjhep.2009.15.3.370
Combination therapy of pegylated interferon alpha and ribavirin has been associated with various adverse effects, but sudden-onset hearing loss is uncommon. We report a 60-year-old male patient who developed sudden-onset... -
- CITED
-
- Close
- SHARE
-
- Close
- Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic Hepatitis
-
Kang HY, Shin MC
- KMID: 1364871
- Korean J Ophthalmol.
- 2012 Apr;26(2):147-150.
- doi: 10.3341/kjo.2012.26.2.147
This paper reports a case of pegylated interferon-associated retinopathy in a patient with chronic hepatitis C. A 32-year-old female with chronic hepatitis C undergoing pegylated interferon and ribavirin combination therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C
-
Kang HM, Park MJ, Hwang JM, Kim JW, Jeong SH
- KMID: 1381442
- Korean J Hepatol.
- 2009 Jun;15(2):209-215.
- doi: 10.3350/kjhep.2009.15.2.209
A 63-year-old male experienced sudden diplopia after 9 weeks of administration of pegylated interferon (IFN) alpha-2b and ribavirin for chronic hepatitis C (CHC). Ophthalmologic examinations showed ptosis on the right... -
- CITED
-
- Close
- SHARE
-
- Close
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C
-
Lim JH, Lee YN, Kim YS, Kim SG, Jeong SW, Jang JY, Kim HS, Lee SH, Park TK
- KMID: 1105515
- Korean J Hepatol.
- 2011 Mar;17(1):61-65.
- doi: 10.3350/kjhep.2011.17.1.61
Vogt-Koyanagi-Harada (VKH) disease is a multisystem syndrome characterized by ocular (uveitis and retinal detachment), neurological (headache, tinnitus, and meningitis), and integumentary (vitiligo, alopecia, and poliosis) involvement. Although the pathogenesis of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Bell's Palsy Associated with Peginterferon Alfa-2a and Ribavirin Therapy for Chronic Hepatitis C Virus Infection
-
Lee MY, Cho H, Kim YM, Lee JS
- KMID: 760677
- Korean J Hepatol.
- 2006 Sep;12(3):444-448.
Pegylated interferon alfa-2a (PEG-IFN) and ribavirin combination therapy is the first line treatment for chronic HCV infection. There are four reports of Bell's palsy associated with interferon-alpha (IFN-alpha) and ribavirin... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea
-
Baeg JY, Kim IH, Seo SY, Kim YS, Jung EU, Cho J, Chung JW, Jang ES, Kim JW, Jeong SH
- KMID: 2412217
- Gut Liver.
- 2017 May;11(3):426-433.
- doi: 10.5009/gnl16242
BACKGROUND/AIMS: The association between depression and chronic hepatitis C virus (HCV) infection or pegylated interferon α and ribavirin therapy (PR therapy) has not been extensively studied in Korea. We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between IPTA Gene Polymorphisms and Hematological Abnormalities in Hepatitis C Virus-Infected Patients Receiving Combination Therapy
-
Hwang JJ, Lo CC, Lin CH, Cheng HS, Hung IW, Tsai WJ, Hung CH
- KMID: 2380767
- Gut Liver.
- 2015 Mar;9(2):214-223.
- doi: 10.5009/gnl14095
BACKGROUND/AIMS: Hematological abnormalities during hepatitis C virus (HCV) combination therapy with pegylated interferon alpha and ribavirin often necessitate dose reduction. Variants of the ITPA gene have been reported to protect... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of and risk factors for thyroid dysfunction during peginterferon alpha and ribavirin treatment in patients with chronic hepatitis C
-
Hwang Y, Kim W, Kwon SY, Yu HM, Kim JH, Choe WH
- KMID: 2381583
- Korean J Intern Med.
- 2015 Nov;30(6):792-800.
- doi: 10.3904/kjim.2015.30.6.792
BACKGROUND/AIMS: Thyroid dysfunction (TD) is more likely to occur in patients with chronic hepatitis C (CHC) and is particularly associated with interferon (IFN) treatment. The purpose of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Entecavir Switching Therapy in Chronic Hepatitis B Patients with Clevudine-induced Myopathy
-
Lee JW, Lee YJ, Lee JJ, Kim JH, Jung YK, Kwon OS, Choi DJ, Kim YS, Kim JH
- KMID: 1775784
- Korean J Gastroenterol.
- 2013 Jan;61(1):30-36.
- doi: 10.4166/kjg.2013.61.1.30
BACKGROUND/AIMS: Clevudine is a potent antiviral agent against HBV. However, long-term clevudine therapy may cause myopathy. This study was carried out to identify the efficacy of entecavir switching therapy in... -
- CITED
-
- Close
- SHARE
-
- Close
- Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C
-
Lee YN, Jeong SW, Lim JH, Ryu YS, Jeon SR, Kim SK, Jang JY, Kim YS, Kim BS, Roh MO
- KMID: 1792598
- Korean J Hepatol.
- 2010 Jun;16(2):187-191.
- doi: 10.3350/kjhep.2010.16.2.187
Combined pegylated interferon and ribavirin therapy for chronic hepatitis C infection cause a wide range of side effects, including flu-like syndrome, hematological abnormalities, cardiovascular symptoms, gastrointestinal symptoms, pulmonary dysfunction, depression,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Osteomalacia Related to Adefovir in a Patient with Chronic Hepatitis B
-
Ahn SY, Ko SY, Jang YM, Choi YH, Kim BK, Choe WH, Lee CH, Kwon SY
- KMID: 1775868
- Korean J Gastroenterol.
- 2010 Aug;56(2):117-120.
- doi: 10.4166/kjg.2010.56.2.117
Adefovir dipivoxil, an acyclic nucleoside analogue, has been approved for the treatment of patients with chronic hepatitis B. This agent is efficacious particularly in those who have developed lamivudine resistance.... -
- CITED
-
- Close
- SHARE
-
- Close
- Interferon-Alpha-Induced Destructive Thyroiditis Followed by Graves' Disease in a Patient with Chronic Hepatitis C: A Case Report
-
Kim BK, Choi YS, Park YH, Lee SU
- KMID: 1786023
- J Korean Med Sci.
- 2011 Dec;26(12):1638-1641.
- doi: 10.3346/jkms.2011.26.12.1638
Interferon-induced thyroiditis (IIT) is a major clinical problem for patients receiving interferon-alpha (IFN-alpha) therapy. But, destructive thyroiditis followed by Graves' disease associated with IFN-alpha therapy is very rarely reported. Herein,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness and Complications of Combination Therapy with Interferon Alpha and Ribavirin in Patients with Chronic Hepatitis C
-
Hwang SY, Lee HJ, Park KT, Kim KY, Lee SM, Park CW, Kim TO, Kim GH, Heo J, Kang DH, Song GA, Cho M, Cho BM
- KMID: 782839
- Korean J Gastroenterol.
- 2007 Mar;49(3):166-172.
BACKGROUND/AIMS: The effectiveness of combination therapy with conventional or pegylated interferon alpha and ribavirin in patients with chronic hepatitis C is well understood. However, the profound investigation about complications of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Primary Neuroendocrine Carcinoma of Liver Presenting with Liver Abscess
-
Lee SH, Kim KA, Lee JS, Oh DH, Bae WK, Kim NH, Moon YS, Kim HS
- KMID: 782778
- Korean J Gastroenterol.
- 2006 Oct;48(4):277-280.
Primary hepatic neuroendocrine cell carcinoma is a very rare tumor. We experienced a 75-year-old woman with primary hepatic neuroendocrine carcinoma presenting with pyogenic liver abscess. Abdominal CT scan revealed a... -
- CITED
-
- Close
- SHARE
-
- Close
- Interstitial Pneumonitis in a Patient with Chronic Hepatitis C and Chronic Renal Failure on Interferon Therapy
-
Kang EJ, Kim DK, Jeon SR, Choi HS, Jeong SW, Jang JY, Lee JS, Uh ST
- KMID: 1792815
- Korean J Gastroenterol.
- 2011 Jul;58(1):47-52.
- doi: 10.4166/kjg.2011.58.1.47
After 4-months of alpha interferon (IFN-alpha), a 64-year old woman with chronic hepatitis C developed a cough and dyspnea and showed diffuse infiltrative opacities on her chest X-ray. Her symptoms... -
- CITED
-
- Close
- SHARE
-
- Close
